Business Description
Adverum Biotechnologies Inc
NAICS : 325412
SIC : 2834
ISIN : US00773U1088
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.29 | |||||
Equity-to-Asset | 0.48 | |||||
Debt-to-Equity | 0.9 | |||||
Debt-to-EBITDA | -0.63 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -7.69 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 4.2 | |||||
3-Year EPS without NRI Growth Rate | 5.6 | |||||
3-Year FCF Growth Rate | 5.3 | |||||
3-Year Book Growth Rate | -43 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 14.73 | |||||
9-Day RSI | 10.94 | |||||
14-Day RSI | 9.67 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.13 | |||||
Quick Ratio | 4.13 | |||||
Cash Ratio | 3.87 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.3 | |||||
Shareholder Yield % | 9.38 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -3444.19 | |||||
Net Margin % | -3254.58 | |||||
FCF Margin % | -2547.5 | |||||
ROE % | -89.22 | |||||
ROA % | -49.02 | |||||
ROIC % | -104.07 | |||||
ROC (Joel Greenblatt) % | -140.16 | |||||
ROCE % | -60.89 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 29.05 | |||||
PB Ratio | 1.27 | |||||
Price-to-Tangible-Book | 1.27 | |||||
EV-to-EBIT | -1.57 | |||||
EV-to-Forward-EBIT | -1.79 | |||||
EV-to-EBITDA | -1.65 | |||||
EV-to-Forward-EBITDA | -1.76 | |||||
EV-to-Revenue | 54.16 | |||||
EV-to-Forward-Revenue | 177.26 | |||||
EV-to-FCF | -2.13 | |||||
Price-to-Net-Current-Asset-Value | 8.01 | |||||
Price-to-Net-Cash | 15.09 | |||||
Earnings Yield (Greenblatt) % | -63.69 | |||||
FCF Yield % | -42.37 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Adverum Biotechnologies Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 3.6 | ||
EPS (TTM) ($) | -11.6 | ||
Beta | -0.24 | ||
Volatility % | 56.42 | ||
14-Day RSI | 9.67 | ||
14-Day ATR ($) | 0.902139 | ||
20-Day SMA ($) | 19.46795 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 8.86 - 22.65 | ||
Shares Outstanding (Mil) | 20.75 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Adverum Biotechnologies Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Adverum Biotechnologies Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Adverum Biotechnologies Inc Frequently Asked Questions
What is Adverum Biotechnologies Inc(LTS:0HA3)'s stock price today?
When is next earnings date of Adverum Biotechnologies Inc(LTS:0HA3)?
Does Adverum Biotechnologies Inc(LTS:0HA3) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |